Functional Capacity Improvement on Patent Ductus Arteriosus with Pulmonary Arterial Hypertension: A Case Report and Literature Review by Rakhmawati, Annis et al.
ACI (Acta Cardiologia Indonesiana) (Vol.5 No.1): 71-79 
71 
 
Functional Capacity Improvement on Patent Ductus Arteriosus with 
Pulmonary Arterial Hypertension: A Case Report and Literature Review 
 
Annis Rakhmawati*, Irsad Andi Arso, Anggoro Budi Hartopo, Lucia Kris Dinarti 
 
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada – 
Dr. Sardjito General Hospital, Yogyakarta, Indonesia 
 
*Corresponding author: 
Annis Rakhmawati, MD, - email: coronagracilis@gmail.com 
Department  of  Cardiology  and  Vascular  Medicine,  Faculty  of  Medicine, Public Health and Nursing, Universitas  Gadjah 
Mada – Dr. Sardjito  Hospital    
Jalan  Farmako  Sekip Utara,  Yogyakarta,  Indonesia  55281  
 
Manuscript submitted: July 1, 2018; Revised and accepted: August 27, 2018 
 
ABSTRACT 
 
Pulmonary artery hypertension (PAH) is a pathophysiological disorder involving a wide range 
of clinical conditions. This can be a condition of complications from heart disease and 
respiratory system. Pulmonary arterial hypertension is defined as an increase in mean 
pulmonary arterial pressure (mPAP) ≥ 25 mmHg at rest assessed by right heart 
catheterization. The cardiovascular rehabilitation program is a set of efforts to improve the 
underlying cause of cardiovascular disease such that it can maintain or restore the best 
conditions and secondary prevention. Cardiac rehabilitation and physical exercise programs 
have the benefit of improving pulmonary vascular endothelial function, physical activity 
capacity and quality of life parameters for PAH patients. A 6-minute walk test can be used to 
assess the functional capacity of PAH patients. 
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INTISARI 
 
Hipertensi arteri pulmonal (PAH) adalah gangguan patofisiologis yang melibatkan berbagai 
kondisi klinis. Ini bisa menjadi kondisi komplikasi dari penyakit jantung dan sistem 
pernapasan. Hipertensi arteri pulmonal didefinisikan sebagai peningkatan mean Pulmonary 
Artery  Pressure (MPAP) ≥25 mmHg saat istirahat dinilai dengan kateterisasi jantung. 
Program rehabilitasi kardiovaskular adalah serangkaian upaya untuk memperbaiki penyebab 
penyakit kardiovaskular yang dapat mempertahankan atau memulihkan kondisi terbaik dan 
pencegahan sekunder. Rehabilitasi jantung dan program latihan fisik memiliki manfaat 
meningkatkan fungsi endotel vaskular pulmonal, kapasitas aktivitas fisik dan parameter 
kualitas hidup untuk pasien PAH. Tes berjalan 6 menit dapat digunakan untuk menilai 
kapasitas fungsional pasien HAP. 
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INTRODUCTION 
Pulmonary artery hypertension 
(PAH) is characterized by an increase in 
pulmonary vascular resistance that lead to 
decrease right ventricular function or 
death.1 In addition to medical therapy for 
PAH, there are studies of cardiovascular 
rehabilitation programs and physical 
exercise programs in PAH patients that 
have positive effects because these 
programs can improve endothelial 
function, physical activity capacity, and life 
quality parameters.2 These programs 
include a series of physical, educational, 
psychosocial and secondary prevention 
activities.3 This case reports the 
improvement of functional capacity in 
patient with patent ductus arteriosus 
(PDA) bidirectional shunt with PAH, by 
means of home-based exercise program. 
 
CASE PRESENTATION 
A 23-year-old woman came with 
postpartum shortness of breath. She was 
reffered from a district hospital with a 
suspicion of atrial septal defect (ASD) on 
P1A0 5 days postpartum. Shortness of 
breath was felt since 32 weeks of 
gestation that increased during activity, 
improves at rest. The legs were swollen 
and the activity was limited. Patient 
routinely checked the pregnancy at local 
Primary Health Care and was advised to 
give birth at a district hospital due to 
suspicion of congenital heart disease. She 
delivered normally; the baby was in a 
good condition. After delivery her baby, 
her complain about shortness of breath 
and swollen legs still persisted, therefore 
she was referred to Dr. Sardjito General 
Hospital for further treatment. History of 
fatigue had been felt since childhood, no 
disturbance of growth. At 9 years old of 
age, she visited a cardiologist and was 
diagnosed with congenital heart disease. 
She was advised to do a surgery due to 
congenital heart disease then, but the 
patient's family were refused.  
On physical examination, we found 
that she was compos mentis. The blood 
pressure was 120/70 mmHg, heart rate 95 
beats per minute (bpm), respiration rate 
32 times per minute and temperature 36.5 
⁰C, SpO2 86%. Jugular venous pressure 
was 2 cmH2O, no lymphadenopathy. 
Examination of the lungs showed vesicular 
voices in both the lung fields, there was no 
rales. Cardiac examination revealed 
cardiomegaly, prominent right ventricle 
heaving, continuous murmur in left 
infraclavicle area. Examination of both 
lower extremities showed peripheral 
edema. 
The laboratory showed hemoglobin 
13.3 g/dL, platelet 261x103/μL, hematocrit 
41%, leukocyte 12.63x103 /μL, creatinin 
0,96 mg/dL, SGOT 58 U/L, SGPT 59 U/L. 
Blood gas analysis FiO2 70%, pH 7.54, 
PO2 51.5 mmHg, PCO2 22,7 mmHg, HCO3 
19.6 mEq/L, AaDO2 412, SO2 50.7 %, PO2 
/ FiO2 75.3. 
Electrocardiography at emergency 
department of Dr. Sardjito Hospital  
showed sinus rhythm, heart rate 95 
beats/min, right axis deviation, right 
ventricle enlargement (figure 1).  
Chest X-ray showed cardiomegaly 
with enlargement of right atrium and right 
ventricle, pulmonary hypertension and 
right lung partial infiltrate due to 
pneumonia (Figure 2). 
The transthoracal echo 
cardiography showed bi directional shunt 
PDA diameter 10.26 mm, dilated RV, LV D 
shaped, LV ejection fraction 75%, normal 
LV diastolic function, decrease of RV 
systolic function (TAPSE 13 mm), severe 
tricuspid regurgitation (TVG 66 mmHg), 
high probability PH (mPAP 26 mmHg) 
(Figure 3). 
The patient was diagnosed as 
bidirectional shunt PDA with PAH. During 
treatment, the patient's condition was 
improved. Patient underwent 6 minutes 
walking distance (6MWD) before 
discharge. Before 6MWD, her blood 
pressure was 88/61 mmHg, HR 100 bpm, 
SpO2 upper limb 88%, SpO2 lower limb 
52%. After 6MWD, her blood pressure 
was 99/66 mmHg, HR 110 bpm, SpO2 
upper limb 82%, SpO2 lower limb 51%. 
She could reach 90 meters, it was 
equivalent to 1.42 mets. 
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Patient was educated about home-
based exercise to walk 30 minutes/day, 5-
7 times/week accompanied by observing 
SpO2 before and after exercise. The 
exercise should be stopped when the 
patient feel shortness of breath or 
decrease of SpO2 >10% from the baseline 
(before exercise) or fatigue (Table 1). 
Evaluation of the exercise should be done 
in 4 weeks. The patient was discharged 
and received sildenafil 40 mg t.i.d, 
bosentan 12.5 mg b.i.d, furosemide 40 mg 
q.i.d, and spironolacton 25 mg q.i.d. 
 
DISCUSSION 
Pulmonary hypertension (PH) is a 
pathophysiological disorder involving a 
wide range of clinical conditions and can 
be a complication of heart disease and 
respiratory system. Pulmonary 
hypertension is defined as an increase in 
mean pulmonary arterial pressure (mPAP) 
≥25 mmHg at rest and assessed by heart 
catheterization.1 Pulmonary hypertension 
is classified into five major groups. They 
are PAH, PH  due to left heart disease, PH 
due to chronic lung disease and or 
hypoxic conditions, PH due to chronic 
thromboembolic disease or other 
pulmonary artery obstruction, and PH of 
unknown cause.1 Echocardiography 
studies found that the prevalence of PH is 
10.5%, including PH from left heart 
disease 78.7%, PH of lung disease and 
hypoxia 9.7%, PAH 4.2% and PH due to 
chronic thromboembolism 0.6% with 
average mortality in cases of PH are 4.5 to 
12.3 per 100,000 population.1  
There are many pathophysiology 
mechanism involved in the cell and tissue 
level of PAH. The overall interaction of 
initiation and progression of the pathology 
process is not well understood. 
Hemodynamic changes of PAH patients 
are associated with complex 
pathophysiology and multifactorial 
pathobiology involving multiple 
biochemical pathways. Increased of 
pulmonary vascular resistance (PVR) is 
associated with vasoconstriction, 
proliferation, pulmonary vascular wall 
obstruction, inflammation, and thrombosis. 
This change involves endothelial cells, 
smooth muscle cells and adventitial 
resident cells.4 In adventitial layer, there is 
increase of extracellular matrix production 
including collagen, elastin, fibronectin and 
tenacillin.1 Inflammatory cells and platelets 
(via serotonin pathway) also play a role in 
the pathophysiology of PAH.1
 
 
 
Figure 1. Electrocardiography found sinus rhythm, heart rate 95 beats/min, right axis deviation, right 
ventricle enlargement. 
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Symptoms of PAH include 
shortness of breath during activity, 
decreased tolerance to physical activity, 
chest pain and syncope. They 
substantially decreased quality of life and 
experienced shortness of breath then 
decreased tolerance to physical activity or 
exercise. This condition occurs due to 
disruption of the gas exchange process 
associated with ventilation-perfusion 
mismatch as well as decreased pulmonary 
venous return flow resulting in decreased 
cardiac output.4 These result in hypoxia, 
decreased oxygen delivery to muscle, 
decreased maximal oxygen consumption, 
anaerobic metabolism and ultimately 
increased ventilation.4 The patient 
complained of fatigue during activity since 
childhood and shortness of breath since 
32 weeks of gestation. 
There have been many studies of 
medical therapy on PAH, but there are 
also other studies suggest that 
cardiovascular rehabilitation and physical 
exercise program have the benefit of 
improving pulmonary vascular endothelial 
function, physical activity capacity and 
quality of life of PAH patients.2 
Cardiovascular rehabilitation programs are 
a set of efforts undertaken to improve the 
underlying cause of heart disease, the 
physical, mental and social conditions of 
patients or who have a risk of 
cardiovascular disease than perform 
secondary prevention. Its goals are 
restoring the patient with heart disease or 
risk factors for heart disease as soon as 
possible to an active and productive life, 
maintaining the patient's best condition, 
stop or slow the progression of 
cardiovascular disease process and 
reduce the risk of mortality and morbidity 
of heart disease.3 
Implementation of cardiovascular 
rehabilitation program consists of 4 
phases, they are phase I, phase II, phase 
III and phase IV. Phase I program is a 
rehabilitation program conducted to 
patients who are still hospitalized. In this 
phase, the rehabilitation program is 
conducted in inpatient room until the 
patient is discharge in order to overcome 
or reduce the negative effects of bed rest 
during hospitalization, reduce the anxiety 
or depression problems caused by the 
illness and the patient is able to perform 
basic activity daily life.3 The programs 
include education of the patient’s 
condition, gradual mobilization, 
physiotherapy according to the patient's 
condition as well as evaluation of fitness 
level and stratification ability before 
discharge.5  In this case, during 
hospitalization, patients and family were 
educated about the patient's condition, 
gradual mobilization begins by sitting, 
walking around the bed and bathroom as 
well as around the treatment room. 
 
 
 
Figure 2. Chest X-ray showed cardiomegaly with enlargement of right atrium and right 
ventricle, pulmonary hypertension and right lung partial infiltrate due to pneumonia. 
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Table 1. The result of home based exercise datasheet performed by patient and supervised by 
family member 
 
 
 
 
The phase II program is a 
rehabilitation program for patients after 
returning home for secondary prevention, 
preparing the patient to return to work, 
perform optimal daily activities and make 
the exercise program safely and 
effectively for the patient.5 Training 
programs conducted in this phase include 
education and counseling for patients and 
family, controlling for patient risk factors, 
prescribing and implementing physical 
exercise programs, evaluating the ability 
or level of fitness of the patient, and 
occupational physiotherapy programs. The 
duration of exercise in phase II is 1-2 
months in 12 practice sessions.6 In this 
case, after returning home, she was 
educated for home based exercise with 
prescription from the hospital. Evaluation 
was done within 30 days post discharge. 
The phase III program is a further 
rehabilitation program after undergoing an 
evaluation of the Phase II program. 
Rehabilitation at this phase can be 
performed at cardiac and vascular 
rehabilitation centers or at home. This 
phase aims to continue the program to 
overcome disease progression, optimize 
physical exercise and continue healthy 
lifestyle independently.6  
Day Distance 
(meters) 
Duration 
(minutes) 
HR 
before 
exercise 
(bpm) 
HR after 
exercise 
(bpm) 
SpO2 before 
exercise (%) 
SpO2 after 
exercise (%) 
Upper 
Limb 
Lower 
Limb 
Upper 
Limb 
Lower 
Limb 
1 90 30 100 110 88 52 82 51 
2 95 30 90 100 89 53 83 53 
3 90 30 100 110 88 53 83 51 
4 100 30 90 120 90 52 84 52 
5 90 30 86 100 88 52 83 51 
6 110 30 90 110 87 53 83 52 
7 130 30 84 100 89 53 83 53 
8 100 30 80 110 88 52 82 51 
9 120 30 90 110 88 53 83 51 
10 150 30 80 120 90 53 83 52 
11 180 30 80 110 89 53 83 53 
12 210 30 90 120 89 53 83 53 
13 200 30 86 100 87 53 83 52 
14 200 30 90 110 88 53 83 51 
15 210 30 84 100 88 52 82 51 
16 240 30 80 110 88 53 83 51 
17 260 30 90 110 88 52 82 51 
18 240 30 80 120 89 53 83 53 
19 280 30 80 110 88 53 83 51 
20 310 30 90 120 90 52 84 52 
21 300 30 80 100 90 52 84 52 
22 350 30 80 110 87 53 83 52 
23 350 30 80 110 89 53 83 53 
24 400 30 90 110 88 52 82 51 
25 400 30 80 90 88 53 83 51 
26 430 30 80 100 90 53 83 52 
27 430 30 100 110 87 53 83 52 
28 450 30 90 110 89 53 83 53 
29 500 30 80 100 88 52 82 51 
30 500 30 80 100 89 53 83 53 
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Figure 3. Transthoracal echocardiography examination showed bidirectional shunt PDA 
diameter 10.26 mm, dilated RV, LV D-shaped, LVEF 75%, normal LV diastolic function, TAPSE 13 
mm, severe tricuspid regurgitation (TVG 66 mmHg), high probability PH (mPAP 26 mmHg). 
 
Programs in Phase III include 
counseling and education for patients and 
family, controlling risk factors for patients, 
measuring fitness and advanced physical 
exercise programs, outdoor exercise, 
functional level evaluation and further 
programs as well as advanced 
physiotherapy, occupational therapy and 
other necessary interventions. The 
duration of the Phase III is 1-3 months.6  In 
this case, a phase III rehabilitation 
program had not been evaluated yet. The 
phase IV program is a rehabilitation 
program conducted independently by the 
patient. This program can be done at 
home or in a community environment such 
as in a heart healthy club. The purpose of 
phase IV is to maintain the patient's health 
condition at the most optimal level. The 
length of the program is a lifetime of 
patients with regular fitness level 
evaluations every 6 to 12 months.7  In this 
case, the phase IV rehabilitation program 
had not been implemented yet. 
Physical exercise on 
cardiovascular rehabilitation program 
should consider the contraindications for 
physical exercise. These include unstable 
angina pectoris, systolic blood pressure ≥ 
200 mmHg and diastolic ≥ 100 mmHg, 
decreased systolic blood pressure ≥20 
mmHg from daily average blood pressure, 
moderate to severe aortic valve stenosis, 
uncontrolled ventricular heart rhythm 
disorders, uncontrolled tachycardia (heart 
rate ≥120 beats/minute), uncompensated 
congestive heart failure, total 
atrioventricular block without a 
pacemaker, acute pericarditis, acute 
myocarditis, new embolism, 
thrombophlebitis, ST depression ≥2 mm 
on resting ECG, and presence of limb 
problems that cause the patient can’t 
perform physical exercise.7 PAH itself is 
not a contraindication for physical 
exercise. In this case, there was no 
contraindication to perform physical 
exercise.  
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Cardiovascular rehabilitation and 
physical exercise programs in PAH 
patients have positive effects, where these 
will lead to improve endothelial function, 
physical activity capacity and quality of 
life.2  In addition, these reduce the 
oxidative stress that occurs in blood 
vessels through increased activity of 
endothelial nitric oxide synthesis which will 
benefit for pulmonary vascular.2 
Evaluation of the rehabilitation program in 
PAH patients are significant increase of 
6MWD test distance, improved patient 
quality of life, maximal work rate, 
maximum heart rate, peak VO2 and VO2 
threshold and anaerobic work rate 
(calculated by gas exchange in patients).2 
These programs can be tolerated without 
reported incidents or adverse events.2 In 
this case, there was a significant increase 
of 6MWD distance for 30 days of exercise 
without complications during and after 
exercise. 
The prescription of physical 
exercise program in PAH patients use the 
principles of FITT (Frequency, Intensity, 
Time and Type), depend on the patient's 
abilities, specific limitations of underlying 
illness as well as the goal of physical 
exercise. Physical exercise in PAH 
patients can be started by warming up for 
5-10 minutes with low-moderate intensity 
then ended by cooling down for 3-10 
minutes. This warming up period is useful 
for warm-up exercises of muscles, 
increased muscle temperature, oxygen 
exchange and increased transmission of 
nerve impulses.6 
The cooling down period to restore 
the condition of the body after physical 
exercise, as well as avoiding the risk of 
post-action bronchial spasms. Physical 
exercise in PAH patients can be done in 
frequency of 3-5 times per week, with the 
supervision of cardiovascular rehabilitation 
expert. Duration of initial physical exercise 
time in PAH patients is recommended for 
30 minutes (range 20-60 minutes) with a 
gradual increase up to 60-90 minutes 
duration if the patient can tolerate 
exercise.6  
The study by Newman and 
Robbins (2006) showed that PAH patients 
who underwent 12-15 weeks of physical 
exercise program, the average 6MWD test 
distance were 439±82 meters.8  In this 
case, the average distance of 6MWD test 
was 400±82 meters during 30 days of 
physical exercise. The 6MWD test is 
considered a test that can be well 
tolerated by the patient. The American 
College of Chest Physicians (ACCP) 
recommends a serial assessment of the 
physical and functional capacity of PAH 
patients using the 6MWD test to assess 
severity of thedisease and response to 
therapy.9 The 6MWD test measures the 
distance that the patient can walk on a flat 
surface within 6 minutes. The test also 
assess the patient's functional capacity at 
the submaximal level.10  Based on several 
previous studies, the distance of the 
6MWD test was considered as an 
appropriate predictor of patient mortality.11  
Oxygen saturation assessment 
during the 6MWD test can use pulse 
oximetry and oxygen saturation during the 
6MWD test can be used to determine the 
degree of hypoxemia in PAH patients 
during the activity. The desaturation 
conditions during the 6MWD test is 
considered as a better predictor factor for 
mortality. Paciocco et al. (2001) published 
that 10% reduction of oxygen saturation 
during the 6MWD test predicted a higher 
mortality rate.12 While other research 
stated that each 10% decrease of arterial 
oxygen saturation level during the 6MWD 
would increase26% of mortality risk. In this 
case, there was no oxygen saturation 
decrease>10% after exercise.10 
Cardio Pulmonary Exercise Test 
(CPET) tests can be safely used in 
patients with advanced respiratory 
diseases, including PAH, with some 
indications such as prognosis 
assessment, disability evaluation and 
monitoring response to therapy.13 The 
peak VO2 assessment during the CPET 
test is a gold standard in the assessment 
of PAH patients. In the CPET test, the 
patient will perform a training test using a 
static ergometer bicycle and the patient is 
asked to breathe through the mouthpiece. 
This test include assessment of the 
respiratory rate, VE, VO2, VCO2, end tidal 
PO2, end tidal PCO2, VE/VO2 and 
VE/VCO2 and peripheral oxygen 
saturation at rest and during the test. 
Assessment is usually done within 3 
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minutes when the patient at rest, 3 
minutes when the patient do static 
ergometer and during progressive 
increases of the work rate. The test is 
stopped when the patients feel worsening 
of the symptoms.14 In this case, we did not 
perform CPET test. 
The gas ventilation disorder 
precipitated by PAH conditions is affected 
by multiple factors and related to the 
severity of PAH. An increase of mean 
pulmonary artery pressure is the most 
important pathophysiological consequence 
of the condition, which leads to an 
imbalance between ventilation and 
perfusion.  
The result of this condition is the 
increase of physiological dead space 
which is indicated by the increase of 
VE/VCO2 ratio and the decrease or 
disappearance of partial pressure of ends 
tidal carbon dioxide (PET CO2).
14 
Increased pulmonary artery pressure may 
also lead to a decrease in blood flow to 
the left heart, thereby decreasing cardiac 
output for a minute. Increased pulmonary 
artery pressure will cause intra ventricular 
septum movement towards the left, this 
will affect the filling of the left ventricle so 
that there will decrease the cardiac output. 
A decrease in cardiac output will 
be associated with decreasing peak VO2 
and VO2 at the time of the ventilation 
threshold. Increasing the PAH severity will 
lead to decrease the red cell transit time in 
the pulmonary circulation so that oxygen 
diffusion will decrease. Further 
desaturation conditions in the arterial will 
enlarge the ventilation response to 
physical activity, increasing the ratio of 
VE/VCO2 and decreasing PET CO2.
14  
 
CONCLUSION 
 
We reported 24-year-old woman 
with bidirectional shunt PDA with PAH 
who underwent  6MWD test and resulted 
in 90 meters at the beginning of the 
exercise. Exercises were done everyday 
then evaluated in 4 weeks. Physical 
exercise programs on PAH remain at risk 
for serious side effects and complications. 
Evaluation of physical capacity in PAH 
patients can be conducted with the 6MWD 
test and CPET. 
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